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Members of the European
Parliament have voted for a ban
on embryonic stem cell research
in a vote pitting Catholic
conservative members from
southern Europe against socialists
and liberals from the north. The
parliament took the first step that
could lead to a ban on a
technology focused on the study
and potential treatment of genetic
diseases.
The practice, which is legal in
the UK but banned in many
European countries, allows
scientists to create human
embryonic stem cells or to use
human embryos donated by
couples undergoing in vitro
fertilisation (IVF) treatment which
would otherwise be frozen or
destroyed.
Although any change in EU
legislation will need the support of
all 15 current member states, the
vote sends a clear message to a
broad group of people working in
the ethically challenging area of
human stem cells.
Last month, EU research
commissioner Philippe Busquin
warned that the ‘skeptical climate’
in Europe over this issue was
scaring biotech companies and
research centres away. The
parliament added some 50
amendments restricting the use of
stem cells to a bill originally
designed only to guarantee safety
standards for the donation,
procurement, testing, processing,
storage and distribution of human
tissues and cells.
A spokesperson for the
European Commission’s research
directorate, which funds European
research projects, said it was
unlikely the bill would be enacted
with these amendments because
many member countries have far
more ‘liberal’ domestic laws on
stem cell research. Two years
ago, both houses of the British
parliament voted to allow stem
cell research. “It’s just the first
reading so it has to go through
further procedures,” he said. “This
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A first round rejection of human stem cell research by the European
Parliament has given supporters the jitters in member states keen to
pursue the potential offered by the new field, shown by a recent
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Thrilled: Shahana and Raj Hashmi, shown here with their son Zain, have been given approval by a team of Britain’s top judges to
pursue efforts to select an embryo for reimplantation that would provide Zain with tissue-matched stem cells to help cure his thalas-
saemia. Such efforts had been banned by a judge in a lower court. (Photograph: Press Association.)
isn’t final. It will certainly influence
the debate, but this is by no
means a final decision.”
Christian conservatives, who
led the attack against stem cell
research, secured a large majority
for most of the amendments.
Marie Louise Flemming, the
Austrian Christian democrat MEP,
who tabled the amendments said:
“From the moment of conception,
you create all the individual
characteristics of a person.” But
David Bowe, a British Labour MEP
who opposed the ban, said: “It
flies in the face of logic and
human compassion to seriously
curtail potentially ground-breaking
areas of scientific research.”
Lord May, president of Britain’s
science academy, the Royal
Society, said: “We are very
disappointed that the European
Parliament has backed this
cynical manipulation of the
legislative process by a small
minority who want to overturn the
rights of individual member states
to make their own democratic
decisions about whether to allow
research on human embryonic
stem cells and therapeutic
cloning.”
He added: “We hope that EU
health ministers will reject these
amendments when they are
presented with the directive in
June.” The European Commission
is due to debate whether it uses
EU money to fund stem cell
research projects, and legislation
is expected before the end of the
year.
The European Parliament’s
unease about stem cell research
followed hot on the heels of
ground-breaking judgment by
Britain’s most senior judges giving
the go-ahead to a couple hoping
to create a baby whose umbilical
cord stem cells could save their
four-year-old son’s life. The case
highlights the tip of the iceberg of
ethical and treatment issues in
stem cell research. The judges
overturned the decision of a lower
court to ban the attempt in spite
of the go-ahead given two years
ago by the Human Fertilisation
and Embryology Authority, the
body which oversees policy in
these areas. Most unusually, the
appeal court judges gave the
couple the green light ahead of
publishing their judgment on how
they had reached their decision
under the existing law.
In December 2001 Raj and
Shahana Hashmi were the first
couple in Britain given approval to
try to create a sibling who would
be a tissue match for a sick
brother or sister. But 12 months
later, after two failed attempts,
they were forced to put any
further treatments on ice, when a
high court judge ruled that the
HFEA had been acting outside its
powers in allowing the technique
of embryo selection by tissue
typing, to go ahead.
We’ve done everything we
can to save Zain’s life. Now
we all have new hope
The HFEA was criticised last
summer by a committee of British
MPs for failing to consult the
public before deciding to allow
the couple to try for a ‘designer
baby’ in the hope of saving the life
of an existing child. Ian Gibson,
chair of the House of Commons
select committee on science and
technology said that their report
was not an attack on the HFEA. It
was, he says, ‘a constructive
attempt to highlight its
weaknesses’ so that it could
become an organisation that
commands respect and
confidence.
The case to block the Hashmi’s
efforts was brought by Josaphine
Quintavalle of the ‘pro-life’ group
Comment on Reproductive Ethics,
which believes babies should be
conceived only for their own
benefit and not to help a sibling.
The technique involves using IVF
to create a number of embryos
and then implanting only those
which have been shown through
tests to be an exact match.
The three appeal court judges
overturned the lower court judge’s
ruling that the HFEA’s powers
were limited to helping women
with fertility problems bear
children.The judges made their
decision to announce the go-
ahead before the legal ruling
because of their appreciation of
the highly time-sensitive nature of
the case. Mrs Hashmi said: “We’re
absolutely thrilled. We’ve done
everything a parent could possibly
do to try to save Zain’s life. Now
we all have new hope.” She also
thought the decision would help
other people. “It opens up the
door to other families in the same
position as us,” she said.
The Hashmis were able to go
ahead immediately with efforts for
new treatment as time is running
out for their son, Zain, who has
beta thalassemia, a disease that
needs frequent blood transfusions
for basic management but offers
little long-term hope. As Zain gets
older, there is less chance that the
few stem cells from the umbilical
cord would produce a result, and
it might then be a question of
applying to the court for
permission to do a bone marrow
transplant with the new sibling as
donor. And this was an issue the
HFEA was not willing to sanction
in its original assessment of
selecting embryos for potential
uses as cord blood donors so this
prospect provides a wholly new,
and much more serious, set of
ethical hurdles for the HFEA and
Zain’s parents. 
Dr Simon Fishel, director of
assisted reproduction at
Nottingham Park hospital, who is
treating the couple, said he was
delighted not only for them but for
the other families who had been
awaiting the judgment. He said he
was advising six couples whose
children had disorders that might
benefit from the technique.
In spite of the euphoria, he put
the Hashmi’s chances of finding
the right embryo at only about one
in 12 and the chances that the
embryo would then result in a live
child at about one in 10. 
The family has sought this
treatment route as they have
failed to find a suitable bone
marrow donor with matching
tissue type through conventional
transplant services available to
patients in such circumstances
seeking a potential donor.
Suzi Leather, chair of the HFEA,
welcomed the judgment, adding:
“Clearly clinicians cannot always
prevent diseases but if they are
able to and also save the life of a
sibling, then this is a legitimate
use of these new techniques.”
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